PetCaseFinder

Peer-reviewed veterinary case report

Changes in gut immune cells and symptoms in dogs

By Schreiner, N M S et al.·Published in Journal of veterinary internal medicine·2008·Federation of Veterinarians of Europe·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Clinical signs, histology, and CD3-positive cells before and after treatment of dogs with chronic enteropathies.

Species:
dog

Plain-English summary

A group of 19 dogs with chronic diarrhea and vomiting were examined to see how well different treatments worked for their inflammatory bowel disease. Ten dogs improved on a special hypoallergenic diet, while nine others needed a steroid medication called prednisolone after their symptoms didn't get better. Researchers looked at tissue samples from the dogs' intestines before and after treatment but found that the usual methods for grading the severity of the disease didn't help distinguish between the two groups or predict how well they would respond to treatment. This means that new ways to assess these conditions may be needed in the future.

People also search for: dog chronic diarrhea treatment · dog vomiting hypoallergenic diet · inflammatory bowel disease in dogs

Abstract

BACKGROUND: Histopathology is widely used for the diagnosis of inflammatory bowel disease in dogs. Variations in lesions and unavailability of uniform grading systems limit the usefulness of histologic examination. HYPOTHESIS: CD3 cell numbers in chronic enteropathies of dogs correlate with clinical activity of the disease and with severity of histopathologic changes. ANIMALS: Nineteen client-owned dogs examined because of chronic diarrhea, vomiting, or both. METHODS: Samples of duodenal and colonic mucosa were collected endoscopically before and after treatment. Dogs that responded to a hypoallergenic diet were grouped as food-responsive diarrhea dogs (FRD, n=10). Dogs with no clinical improvement after 10 days of treatment then received prednisolone (immunosuppressive doses) and were grouped as steroid-responsive diarrhea dogs (SRD, n=9). Histopathologic assessment with a standardized grading system was performed retrospectively on the intestinal samples. Histologic score, total number of infiltrating cells, and CD3-positive cells were counted and compared with the clinical scoring. RESULTS: No statistically significant difference was detected among histologic grading, total number of cells in the lamina propria, and T-cell numbers in biopsies before and after treatment in either group (FRD and SRD). CONCLUSIONS AND CLINICAL IMPORTANCE: Currently used histopathologic grading scores, total numbers of cells, and numbers of CD3-positive cells did not allow differentiation between FRD and SRD and did not correlate with clinical response to therapy. Based on these results, new grading scores assessing other criteria than total cell numbers and CD3-positive cells should be evaluated in the future.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/18673423/